Navigation Links
Molecular glue with new effect
Date:1/31/2008

This release is also available in German.

Ten years ago, researchers at the IMP - a basic research institute in Vienna - discovered a fundamental and amazingly plausible mechanism of cell division. They identified a protein complex, which, as a ring-shaped molecule, slides over the doubled chromosomes and holds precisely these together until the time they again separate. Because of its function as molecular glue, the protein complex was given the name cohesin.

In the working group of Jan-Michael Peters, Senior Scientist at the IMP, the molecule was continually monitored over the last ten years. Now Peters and his colleague, Kerstin Wendt, in cooperation with Katsuhiko Shirahige from the Tokyo Institute of Technology, were able to find evidence of another, also essential function of cohesin. As the researchers report in the online issue of the journal Nature, the molecule acts as a regulator of gene expression, and therefore plays an important role in the reading of genes. The molecule fulfills this function entirely independently of its thus far known activity.

Various inhibiting and promoting elements within the genome affect whether genes can be read in a particular situation and how intensively this process proceeds. Promoters initiate the reading process, whereas enhancers strengthen it, and silencers suppress it. The combination of these factors must be very finely tuned. The areas that are each influenced by the regulators are separated from each other by so-called insulators. It has now been ascertained at the IMP for the first time ever that cohesin is necessary for the function of such insulators.

This discovery not only enriches basic research by contributing to further fundamental knowledge. It should also be of medical interest: a number of rare but serious disorders can be traced back to mutations in cohesin. If the regulation of gene expression proceeds abnormally, developmental disorders are the result. The range of symptoms extends from subtle and hard-to-diagnose changes to massive, physical and cognitive impairments. One of the more well-known disorders of this kind is called Cornelia de Lange Syndrome. Affected persons suffer from numerous anomalies and malformations. A causative treatment is not available.

We cannot cure the disease, but we now know the molecular mechanisms that cause it. This helps us to better understand the disorder and its symptoms. Moreover, we expect that our findings will stimulate new exciting research, stated Jan-Michael Peters.

A valuable resource for this has already been created by the researchers in the course of their work: they have systematically searched the entire human genome for cohesin binding sites that is, the areas where cohesin is effective. Thus, the first genome-wide cohesin map in a mammalian species was developed. The database is open to the entire scientific community.


'/>"/>

Contact: Heidemarie Hurtl
hurtl@imp.ac.at
43-179-730-3625
Research Institute of Molecular Pathology
Source:Eurekalert

Related medicine news :

1. Story ideas from Molecular and Cellular Proteomics
2. Findings point to molecular Achilles heel for half of breast cancer tumors
3. The Journal of Biomolecular Screening garners Association TRENDS Bronze Award
4. Molecular pathway appears crucial in development of pulmonary fibrosis
5. New book presents comprehensive survey of research into the molecular basis of aging
6. Childrens Hospital researchers identify molecular switch that could save very young lives
7. In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly
8. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
9. A molecular map for aging in mice
10. Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008
11. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ( ... patients about the safety issues related to dental restorations. According to the American Academy ... to reach $6.4 billion in 2018 with more than 30 million Americans missing all ...
(Date:12/8/2016)... ... 08, 2016 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it had joined the Pharmaceutical Supply Chain Initiative ... to unite pharmaceutical and healthcare companies that share a vision of better, social, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter ... communities in and around the greater Phoenix metropolitan region, is announcing a charity ... The mission of the Homeless Youth Connection is to promote community awareness of ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again ... that it is one of the early adopters completing EU-U.S. Privacy Shield Certification from ... to provide companies on both sides of the Atlantic with a mechanism to comply ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
(Date:12/8/2016)... 2016 A Small Business Innovative Research (SBIR) ... Health (NIH) to Phoenix -based NeuroEM ... The grant will seek to determine an optimal set ... electromagnetic waves to treat Alzheimer,s Disease. The grant will ... possibly treat other neurologic disorders such as Parkinson,s Disease ...
Breaking Medicine Technology: